Agilent Technologies (NYSE:A) Coverage Initiated by Analysts at Piper Sandler

Analysts at Piper Sandler began coverage on shares of Agilent Technologies (NYSE:A) in a note issued to investors on Thursday,Benzinga reports. The brokerage set a “neutral” rating and a $150.00 price target on the medical research company’s stock. Piper Sandler’s price target suggests a potential upside of 13.74% from the company’s previous close.

A number of other analysts have also weighed in on A. Morgan Stanley reduced their price objective on shares of Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating on the stock in a research report on Tuesday, March 3rd. Wells Fargo & Company dropped their target price on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research note on Thursday, May 28th. Bank of America upgraded shares of Agilent Technologies from a “neutral” rating to a “buy” rating and dropped their target price for the stock from $150.00 to $145.00 in a research note on Thursday, May 28th. Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. Finally, TD Cowen upped their target price on shares of Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $160.93.

Agilent Technologies Stock Performance

Agilent Technologies stock opened at $131.88 on Thursday. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. Agilent Technologies has a 1-year low of $108.35 and a 1-year high of $160.27. The firm has a market capitalization of $37.25 billion, a P/E ratio of 26.48, a price-to-earnings-growth ratio of 2.41 and a beta of 1.26. The company’s 50-day moving average is $119.63 and its 200 day moving average is $128.00.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company had revenue of $1.84 billion for the quarter, compared to analyst estimates of $1.80 billion. During the same period in the prior year, the company posted $1.31 EPS. The firm’s revenue for the quarter was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Research analysts forecast that Agilent Technologies will post 5.99 EPS for the current year.

Hedge Funds Weigh In On Agilent Technologies

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Optiver Holding B.V. bought a new position in shares of Agilent Technologies during the first quarter valued at approximately $496,000. Ritter Alpha LP bought a new position in shares of Agilent Technologies during the first quarter valued at approximately $203,000. Summitry LLC boosted its stake in shares of Agilent Technologies by 8.1% during the first quarter. Summitry LLC now owns 673,954 shares of the medical research company’s stock valued at $76,817,000 after purchasing an additional 50,441 shares in the last quarter. Segall Bryant & Hamill LLC bought a new position in shares of Agilent Technologies during the first quarter valued at approximately $9,041,000. Finally, Essential Partners LLC boosted its stake in shares of Agilent Technologies by 35.1% during the first quarter. Essential Partners LLC now owns 2,658 shares of the medical research company’s stock valued at $303,000 after purchasing an additional 690 shares in the last quarter. 87.41% of the stock is currently owned by institutional investors.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.